Please provide your email address to receive an email when new articles are posted on . Clinical response was noted in 47.6% of patients treated with oral vancomycin therapy for IBD associated with ...
A retrospective study was conducted with adult inpatients over age 18 years who were initiated on vancomycin between August 1 and September 30, 2006 (preimplementation group), and between March 1 and ...
The concomitant use of vancomycin and piperacillin-tazobactam has been the focus of increasing clinical scrutiny due to its association with acute kidney injury (AKI). Vancomycin, a potent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback